The belief that KRAS, NRAS, and HRAS mutations are found in nearly one-third of all cancers helped motivate the creation of high-profile major research programs that focused on RAS,9 but our study found that only approximately 15% of all cancer patients have KRAS, NRAS, and/or HRAS mutation. This evidence concerns the gene KRAS and cancer.